Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 as adjunct therapy after primary angioplasty in acute STEMI
IRCT20120215009014N407Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Coenzyme Q10 adjunct therapy with Placebo adjunct therapy (2 arms). Primary endpoint: Paraclinical outcomes after primary angioplasty. Started Dec 2021; status: completed.
02
Drugs
coenzyme q10
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20120215009014N407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N407.